Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q2- Text added to 2019 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
article, Biopharma, Blueprint, broader, bulk, Canada, Chancery, chemoradiation, Circuit, colorectal, concurrent, cycled, device, distortion, encourage, fullest, heard, incentivize, Mine, NaN, passed, pharmacy, placebo, pocket, prioritize, proceed, retreatment, role, Seattle, surgery
Removed:
assessed, auditor, correlation, cyber, paper, quotation, supported, technique
Valuein 2019 Q2 filing- Value in 2019 Q3 filing
Original filings
Filing view